# OnCo record vein-to-vein-time (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/vein-to-vein-time/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "vein-to-vein-time" ;
  schema:name "Vein-to-vein time and manufacturing slots"@en ;
  schema:alternateName "vein-to-vein"@en, "vein to vein"@en, "manufacturing time"@en, "manufacturing slot"@en, "manufacturing slots"@en, "turnaround time"@en, "manufacturing failure"@en, "out-of-specification"@en, "OOS product"@en, "slot allocation"@en, "chain of identity"@en, "chain of custody"@en, "cryopreserved product"@en, "fresh product"@en, "manufacturing failures"@en ;
  schema:description "For CAR-T, the number of days from collecting the patient's cells to infusing the finished product, typically three to six weeks. Every day counts when the disease is aggressive, and manufacturing capacity (slots) limits how many patients can be treated."@en ;
  schema:url <https://onco.cc/terms/vein-to-vein-time/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Chimeric_antigen_receptor_T_cell> ;
  schema:citation <https://en.wikipedia.org/wiki/Chimeric_antigen_receptor_T_cell> ;
  onco:related <https://onco.cc/terms/apheresis/>, <https://onco.cc/terms/bridging-therapy/>, <https://onco.cc/terms/lymphodepletion/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/closed-automated-cell-manufacturing/>, <https://onco.cc/technologies/point-of-care-cell-manufacturing/>, <https://onco.cc/technologies/cell-therapy-orchestration-software/> .